Covid-19 Update

Jeremy Hunt Excerpts

Tuesday 2nd March 2021 Commons Chamber

[Matt Hancock]

The right hon. Gentleman says he likes it. We always knew that he was misplaced over there. His problem is that sometimes his rhetoric is aimed more at his Back Benchers than what he thinks is right. I urge him to listen to his conscience and to back us and the businesses that are making this vaccination roll-out happen, and to put that support into practice.

The right hon. Gentleman asked about sequencing—again, done by a brilliant combination of academics, Government and private businesses. We are now sequencing a third of the positive tests in this country. That is not yet a full survey of all the positives, although we are working towards that, but it does mean that we are able to spot the variants much more than anywhere else in the world. We currently provide around 40% of the total global sequences of this disease—this virus—and we are driving up that sequencing capacity.

The right hon. Gentleman asked about increasing the uptake of vaccination. He was quite right to, and we are working with faith groups and local directors of public health and others. Councils have a very important role to play alongside pharmacists and, of course, GPs in increasing the vaccination uptake. However, the vaccination uptake has been very, very high—higher than I expected—and I am really thrilled about that.

Finally, the right hon. Gentleman asked about making sure that the road map follows data, not dates. We have rigorously set out the gap between the steps to ensure that we can see the effect of one step before we take the other. That is with the goal of having this road map as a one-way route out of restrictions so that we can all get back to the freedom that we crave.

[Jeremy Hunt (South West Surrey) (Con) [V]]

I congratulate the Health Secretary on the brilliant progress of the vaccine roll-out, which is a personal achievement for him as well as a collective achievement for the Government. I also thank him for transparency in that programme and the transparency on the risks of the new Brazilian variant.

I would like to ask about transparency in another area, which is the new integrated care systems that he is planning in his White Paper and the concerns expressed by the Nuffield Trust, the King’s Fund, the Health Foundation and NHS providers at this morning’s Health and Social Care Committee about the lack of detail on how the public will know how well their local ICS is doing. Sir Robert Francis told the Committee that he favoured asking the CQC to Ofsted-rate the new ICSs and I wonder whether my right hon. Friend thinks that that might be a solution to the accountability issue.

[Matt Hancock]

Transparency has played a vital role in our approach to responding to this virus, and I think that is an important lesson from it that should be heeded globally. In terms of the future of the NHS arranged around the ICSs, that transparency will be important, too. There will be a crucial role for the Care Quality Commission, which currently rates hospitals according to, as my right hon. Friend put it, an Ofsted-style rating. It is vital that the CQC has a similar role when it comes to ICSs, and I look forward to working with him and other members of his Committee to make sure that we get the details of that right.

Oral Answers to Questions

Jeremy Hunt Excerpts

Tuesday 23rd February 2021 Commons Chamber

[Matt Hancock]

The hon. Lady is a long-standing and passionate campaigner for Kuvan, and I pay tribute to the work that she has done. The NICE methods review looks at the question she raises. It is important that we have a clinically-led process for approval of medicines, and I know she agrees with that. The question is ensuring that the details live up to that principle. The methods review will make sure that we take advantage of advances in medical technology, which will, I hope, allow us to bring drugs and treatments to patients of rare diseases who need them more quickly than in the past.

[Jeremy Hunt (South West Surrey) (Con) [V]]

Can I add my support to the previous question about the urgent need to sort out the issue of Kuvan, because I too have constituents suffering very badly from the long wait that they have had?

I wanted to talk to the Secretary of State about support for NHS frontline staff, who have done such a magnificent job this year but worry that, even now, we are not training enough doctors and nurses for the long-term needs of the NHS, and that is the crucial way that we will reduce the pressure on them. So could I ask him: will he be publishing a workforce plan this year, will that have independent projections as to the number of doctors and nurses the NHS will need in every specialty over the next couple of decades and will he commit to funding the number of training places that we need to make sure that we meet those needs of the future?

[Matt Hancock]

The good news is that, thanks in part to the work that my right hon. Friend did when he was in my shoes, we now have a record number of doctors in the NHS and he will have been as pleased as I was to see the record number of applicants to nursing places as well, because we need both more doctors and more nurses. I am delighted that, during the pandemic, we have increased numbers very substantially. On nurses, we are on track to meet our manifesto commitment to 50,000 more nurses, and we have seen a significant increase—just under 10,000—in the number of doctors too, so there is significant progress. Of course there is more to be done, and of course we will need to set out the route to that, as he suggests. The time is not quite right now, because right now there are still very urgent needs and pressures, thanks to the pandemic—I am sure that he and the Select Committee understand that—but this is undoubtedly a question that we will return to.

Future of Health and Care

Jeremy Hunt Excerpts

Thursday 11th February 2021 Commons Chamber

[Matt Hancock]

I will take that as cautious support. I know that the hon. Gentleman sometimes has to say these things, but I am very glad that he leaves the door open for yet more enthusiastic support in the future, not least because of all the questions that he just asked. The proposals on the table—the proposals in the White Paper—are addressed directly to make the improvements that he calls for.

The hon. Gentleman raised an important point about the vaccination programme. The vaccination programme is one of the largest and also one of the most successful civilian operations that has happened in this country, and that is because of the teamwork among the NHS, local authorities, the Department and the brilliant civil servants who work in the vaccine taskforce. It is that combination, that teamwork and that integration which is making the programme the great success that it is.

The hon. Gentleman asked about timing, and I say to him: why argue for delay? Why stop work to integrate? Why stop work to ensure the NHS is more accountable? When people are working so hard in the NHS for us, why should we not work hard in this Parliament to give them the legislative support that they need and have asked for? That is the question he needs to answer if he wants to continue an argument for delay. If not now, when? There is no better time than immediately, so I hope that he will, on reflection and on reading the White Paper, come forward with enthusiastic support.

I absolutely look forward to debates about the details and the implementation. I look forward to the parliamentary passage of a significant piece of legislation in the future, and I look forward to the hon. Gentleman’s engagement on that, but the removal of bureaucratic barriers cannot wait. The increase in the integration of the system should not have to wait, and accountability for this enormous amount of taxpayers’ money to this House, and through this House to the citizens whom we serve, is something that should be welcomed right across this Parliament, and I hope that it will be.

[Jeremy Hunt (South West Surrey) (Con) [V]]

May I start my comments by thanking the brilliant staff at the Royal Surrey County Hospital for the wonderful care they gave me—this morning, as it happens, when I unfortunately slipped over and broke my arm on a morning run. I have just come from the hospital.

It is a very big deal to do a structural reorganisation of the NHS, and I know from my time as Health Secretary how distracting it can be, but it is none the less the right thing to do and a brave thing to do, because NHS staff want nothing more than to be able to give joined-up care—joined up between hospitals, GP surgeries, the social care system and community care—and the current structures make that more difficult than it should be.

I also welcome the public health measures, particularly on obesity, given the high mortality rates that obese people have had during the pandemic. However, these integrated care systems are going to be very powerful, so my question to the Health Secretary is this: how will the public know in their area about the quality and safety of care, and whether waiting lists are being properly managed? How will they know how good all that is? Is he planning to ask the CQC to do Ofsted ratings, as it successfully does for hospitals and GP surgeries?

[Matt Hancock]

I pay tribute to my predecessor’s work setting up integrated care systems in the first place. In a way, this legislation builds on the foundations that he laid when he was in my job, and I look forward to working with the Health and Social Care Committee on the legislation as it proceeds. We have already had discussions, and I am grateful for the Select Committee’s work so far and the insights it has provided.

The question my right hon. Friend raises about the accountability of ICSs is absolutely central, not just to accountability for the use of taxpayers’ money, but to driving up both the quality of care for patients and the health of the population the ICSs serve. It is critical that we ensure the correct combination of high levels of transparency, the role of the CQC as inspector, and accountability up from the ICS, through NHS England, to Ministers and therefore Parliament, and through our democratic processes to taxpayers. The White Paper sets out at high levels how that accountability will work. The details will be a matter for the Bill. The combination of transparency and clear lines of accountability are vital to make sure that while we use the integration provided for in the Bill to empower frontline staff to deliver care better, they are held to account for the delivery of that care and, critically, the outcomes for the population as a whole whom we serve.

Covid-19 Update

Jeremy Hunt Excerpts

Tuesday 9th February 2021 Commons Chamber

[Matt Hancock]

I was listening very carefully to the hon. Gentleman, and I think I take that as support for the measures we are bringing in.

On the specific points the hon. Gentleman raises, he is absolutely right that further driving up vaccination rates is critical. I am delighted by the vaccination rates and the uptake of over 90% in all of the groups over the age of 75, and rapidly rising now—above 75% and rising fast—in the 70 to 74s. I agree with him very strongly on the need to keep driving up the uptake of the vaccine. The Minister for Covid Vaccine Deployment, my hon. Friend the Member for Stratford-on-Avon (Nadhim Zahawi), is leading the efforts across the NHS and local authorities to try to make sure that we can increase vaccination rates further. Nevertheless, the take-up has been absolutely superb so far, and there is still more to do.

I will absolutely look into the points the hon. Gentleman made about Leicester. I know that it is close to his heart and a very important matter.

I will commit to the hon. Gentleman to keep the red list up to date. It is important that we take the measures that are necessary to protect this country. There are countries around the world on a so-called green list that have very low rates of infection and no known variants of concern. I am absolutely in favour of keeping the red list up to date, but I also think it is important that we are proportionate when there are countries that do not have a record of variants of concern. However, we will use the fact that we will sequence every positive test from somebody who comes through the border as a global system of vigilance to make sure that we are always looking for those variants of concern.

The hon. Gentleman raised the issue of financial support. I reiterate that the £500 support is available for anybody on low incomes, so people should come forward for testing in all circumstances. I am absolutely delighted at the level of testing as well. There is now an average of over 650,000 tests a day done in this country, which is obviously a very substantial number.

The hon. Gentleman raised the point about air filtration systems, which are important. I will point him to guidance from the Business Department on air filtration systems and on PPE—we have taken clinical advice and follow the clinical advice on the correct levels of PPE.

Finally, I know that the issue of children of alcoholics is very close to the hon. Gentleman’s heart and to those of many colleagues across the House, so I will absolutely look at how we can ensure that the extra funding we have provided in this space continues to support the vital work not just of those in the NHS, but especially of charities that do so much in this space. The invitation to run the marathon with him is a very interesting one. I am not sure I have enough time for training this year, but it is certainly something I would like to do at some point in the future.

[Jeremy Hunt (South West Surrey) (Con) [V]]

I strongly support the new measures. The higher the number of new daily cases, the more opportunities for variants and mutations to emerge, including ultimately some that may be immune to the vaccine. So does the Health Secretary agree that the central priority now must be to bring down the number of new daily cases, and as we do that, is he planning to introduce enhanced contact tracing for all new cases, including Japanese-style backward contact tracing and genomic sequencing of every new case?

[Matt Hancock]

We have the biggest genomic capacity in the world by some margin, and when the number of cases comes down, as our genomic capacity continues to expand—we plan to more than double it in the coming months—I hope to get to the position where we can genomically sequence every positive case, yes, but we are not there yet.

The strategy that I outlined to tackle new variants, of which the border measures are an important part, is itself one part of the four conditions that the Prime Minister set out for when we can lift measures. The other three are the successful roll-out of the vaccine, which is going very well, and the fall in the number of hospitalisations and the fall in the number of deaths, both of which, as I said, are moving in the right direction but are still too high. Therefore, this strategy to tackle new variants is crucial. The number of cases is a factor, because that itself determines the number of new variants. The conclusion of all that is that we must all stick to the rules now, and the more we stick to the rules now, the sooner we can get out of this.

Covid-19 Vaccine Update

Jeremy Hunt Excerpts

Thursday 4th February 2021 Commons Chamber

[Nadhim Zahawi]

I am grateful to the hon. Gentleman for his constructive way of engaging with the vaccination deployment programme. On trials, we have two running currently, both with Public Health England. The Vivaldi trial is testing residents of care homes, who were in category 1 of the JCVI categories. The second is Siren, which is testing frontline health workers, who are in category 2. As Jonathan Van-Tam, the deputy chief medical officer, has said, we will know the infection and transmission data from those trials in the next few weeks. Of course, the Oxford data is very promising—it needs to be peer reviewed—but those trials will also capture the Oxford vaccine, because obviously that came on site in January.

On the priority list, the JCVI looked very closely at both black, Asian and minority ethnic and, of course, other considerations, including by profession, and came down clearly on the side of age as the deciding factor in people’s risk of dying from covid. This is a race against death, hence the nine categories, which we are going through, and we will continue to do so. A number of professions will be captured in those categories. Of course, those with extremely severe illness will be captured in the category for the severely extremely vulnerable, and others will be captured in further categories down the phase 1 list.

I certainly think it would be wrong to change the JCVI recommendation, because categories 1 to 9 account for 99% of mortality. When we get into phase 2, we would welcome a debate and, of course, will ask the JCVI about including professions such as teachers, shop workers and police officers, who through their work come into contact with much greater volumes of the virus than others do, and it will advise us accordingly.

On BAME and ethnicity, the NHS now collects such data, and we are publishing it. We are doing an enormous amount of work not only across Government, but with the NHS, to ensure that we bring in local government so that we can begin to share data. I would welcome us working much closer with local government and the NHS so that we can identify, to the individual level, the people we need to protect as soon as possible.

I put it on the record that I want clinical commissioning groups to share data with MPs. Several colleagues—[Interruption.] Including you, Madam Deputy Speaker; I can see you nodding away vigorously. CCGs should and must engage with local politicians, because MPs get a lot of emails and telephone calls from concerned constituents in the top four most vulnerable categories. Of course, the NHS has plans to publish CCG-level data very soon.

As for care home staff, we had a fantastic response through the care home vaccination programme, which is category 1, and we continue to do more with staff to encourage them to be vaccinated, because we make four visits into care homes. Visit one is for the first dose, visit two is to try to vaccinate those who may have been infected the first time, because people cannot be vaccinated until after 28 days, visit three will be for second doses, and so on. We are getting greater traction with care home staff, but the hon. Gentleman is right to mention that. There is a big focus on helping them to go to hospital hubs and, of course, their primary care networks.

On the second dose, everyone who has had a first dose of Pfizer will get a second dose of Pfizer within that 12-week dosing period. That will begin in March in the usual way that the NHS does vaccinations. Everyone who has had a first dose of Oxford-AstraZeneca will get a second dose of Oxford-AstraZeneca within 12 weeks as well.

The hg is right to ask about people wanting the option of going either to a national vaccination centre or to the PCN. If right hon. and hon. Members have particular cases, please point them to us and we will do everything we can to ensure that that is facilitated.

The hon. Gentleman rightly highlighted HIV clinics. I will take that matter away and see whether there is a workaround for those who want to have that information remain private from their GP. We will see what we can do.

This is World Cancer Day, and there is now real excitement in the scientific community in the UK about the messenger RNA vaccine, because people can begin to think about vaccines for cancers as well. However, the hon. Gentleman raises an important point about those who care for the clinically extremely vulnerable, and we want to ensure that we deliver the JCVI phase 1 and then very quickly reach the rest of the population.

[Jeremy Hunt (South West Surrey) (Con) [V]]

I congratulate the Minister on his leadership of the vaccine roll-out programme, which really is one of the most impressive anywhere in the world. Indeed, I also commend the Health Secretary for the foundations that he laid last year.

Now that we know that mutations and variants are the name of the game, I want to ask the Minister about a worst-case scenario: a variant that is wholly immune to the vaccines that we are currently distributing. How possible is it that we could see that in the next few months in the UK? Has the Manaus variant, which people are particularly worried about, arrived here from Brazil? If we did see such a variant, what is the timescale not just to develop a new vaccine that works against it, but to manufacture it and get it approved by regulators so that it is ready to go?

[Nadhim Zahawi]

I am grateful to the Chair of the Health and Social Care Committee for his question, and he is absolutely right. The manufacturers are already working on variants to their vaccine to take into account the mutation of the virus. Viruses will mutate to survive and this virus is no different. There are about 4,000 mutations now around the world, some more concerning than others. We have, in the United Kingdom, a genome sequencing industry that is a world leader—about 50%, or just under, of the sequencing has taken place in the United Kingdom. Not only are we working with the current manufacturers—Pfizer-BioNTech, AstraZeneca and Moderna —that have been approved, but we are also looking at how we can make sure that we make the most of the new messenger RNA technology, which allows the rapid development of vaccine variants that will then deal with the virus variants as rapidly as possible. When I spoke to the Science and Technology Committee a few weeks ago, I said that we were planning to have in place the ability to go from the moment that we can sequence a variant that we are really concerned about to the moment that we can have a vaccine ready in between 30 to 40 days, with then, of course, the manufacturing time.

We have invested in Oxfordshire, in the Vaccines Manufacturing and Innovation Centre, and in the Cell and Gene Therapy Catapult Manufacturing Innovation Centre in Braintree—£127 million there and just shy of £100 million in Oxfordshire—to be ready to manufacture any vaccine that we would need. The Prime Minister, of course, also visited those making what I refer to as our seventh vaccine, the Valneva vaccine. That is a whole inactivated virus, so it does not just work on the spikes in the way that the two current vaccines that we are deploying work. It works on the whole of the virus, which is much more likely to capture any mutations from the spikes and therefore be incredibly effective. We have invested in that production facility in Scotland so that we can have that vaccine as a future-proofing of annual vaccination strategies or a booster in the autumn, if necessary.

Covid-19 Update

Jeremy Hunt Excerpts

Tuesday 2nd February 2021 Commons Chamber

[Matt Hancock]

To answer the hon. Gentleman’s many questions, he is absolutely right to raise the importance of coming down hard on the cases of new variants that we have discovered here in the UK. These are cases that have been seen over the past two months. The action that we are putting into place is to make sure that we stop further spread, and further spread in the community, alongside the action taken to ensure that there is no spread from those who have a history of international travel. As he knows, we have brought in tougher action at the border and we stand ready to do more.

The hon. Gentleman asks for the SAGE minutes to be published. They are published regularly. He also asks about the neighbouring postcodes to those where a new variant case has been found, where it is a new variant of concern. We absolutely do that where it is epidemiologically sensible. For instance, if the case is found on the border of a postcode, obviously we go across that border. We also investigate linked premises—for instance, if somebody had a child at a school or is going to work in a particular workplace—and, working with the director of public health, we will ensure that testing is directed there as well.

The hon. Gentleman raises the issue of isolation payments. We have the £500 isolation payment in place, so nobody should, as he put it, go hungry because they have to isolate. What is critical in these areas is that people stay at home unless they absolutely have to go out. It is imperative that people follow the rules to get these new variants completely under control.

He asks about the care home success. I am delighted that we have been able to reach so many care homes. I said in my statement that we have reached 10,307 care homes in England. There are 110 care homes where the vaccination programme is still outstanding because they have had outbreaks and, for clinical reasons, the vaccination programme cannot start there, but it will as soon as it is clinically possible.

The hon. Gentleman also asks about the data being shared from the vaccination programme. That data is now routinely shared with local directors of public health, precisely for the reasons that he set out—so we can reach more parts.

Finally, he ends on the question of education. Of course we understand how challenging the impact of this lockdown is on those with children who have to be schooled at home. That is why the Prime Minister said that schools should be the first thing to open when it is safe and possible to do so. Sadly, that time is not yet, but the more that we all follow the rules that we have set out so clearly, the quicker that time will come.

[Jeremy Hunt (South West Surrey) (Con) [V]]

I thank the Health Secretary for liaising with me on the issues in Surrey over the weekend, where the actions taken by him and the outstanding leader of Surrey County Council, Tim Oliver, are absolutely right. My right hon. Friend mentioned that, at the weekend, we reached the milestone of offering the vaccine to everyone in care homes, except for where there has been an outbreak. Does he agree that we should crown that tremendous achievement by making 2021 a year as significant for the social care sector as 1948 was for the NHS—the year it was founded—with a long-term financial settlement implementing Dilnot and setting it up for the future with a 10-year plan?

[Matt Hancock]

My right hon. Friend knows that we set out in our manifesto, committed in the manifesto and were elected on a manifesto to resolve the long-standing problems in social care. The Prime Minister has set out to the Liaison Committee, of which my right hon. Friend is a member, the timetable on which he hopes that we are able to deliver that commitment. Alongside dealing with this pandemic, we are working to deliver our manifesto commitments, whether on social care or the 40 new hospitals or the 50,000 more nurses. I look forward to being held to account by the Select Committee on Health and Social Care on those commitments.

Vaccine Roll-out

Jeremy Hunt Excerpts

Thursday 21st January 2021 Commons Chamber

[Mr Speaker]

Let us head to Surrey with the Chair of the Select Committee, Jeremy Hunt.

[Jeremy Hunt (South West Surrey) (Con) [V]]

Thank you, Mr Speaker. This week the Office for National Statistics said that prevalence rates nearly doubled during the November lockdown, and today’s REACT—real-time assessment of community transmission—study says that infections are still rising. Is not the reality that these new strains are massively more dangerous and harder to control than many realise? If we are going to bring down the horrific death rates that we are now seeing, should we not secure our border, with quarantine hotels, end household mixing outside bubbles, and follow Germany in mandating FFP2—filtering face piece—masks in shops and on public transport, to give better protection to wearers?

[Matt Hancock]

We have looked at the question of personal protective equipment with respect to the new variant, and the clinical advice I have received is that the current guidelines are right and appropriate. On international travel, as my right hon. Friend knows, we brought in significant measures last week to close the travel corridors, and we remain vigilant on what we need to do to guard against new variants coming in from abroad. The new variants do change this question, because it is about ensuring not just that we do not get extra cases coming in from abroad—in which case, if an area of a country has a lower case rate than us, there is no more risk than that of people staying in this country—but that new variants that might not be dealt with as effectively by the vaccine do not arrive and that we stop them coming. That is something on which have recently taken significant action, and of course we keep it under very close review.

Mental Health Act Reform

Jeremy Hunt Excerpts

Wednesday 13th January 2021 Commons Chamber

[Matt Hancock]

I welcome the comments of the SNP spokesman, and I appreciate her support and thoughtful questions. She is quite right about ensuring that we address the challenges that present themselves for people with autism who are, as she says, disproportionately likely to end up in the criminal justice system. This is an issue on which I have worked very closely with my right hon Friend the Lord Chancellor; I am delighted that he has been able to join us for this discussion.

Part of the point of separating the attitude in law towards those with mental ill health and those with learning disabilities and autism also relates to treatment when there is an interaction with the criminal justice system. It is absolutely critical to get this right. It is difficult, and a huge number of people are working very hard to get this right on the frontline, but at the moment they are hampered by the law when it comes to how that can happen. I hope that in the future they will be supported by the law such that they can make sure people get the right support and the right treatment, whether those people are in the criminal justice system or—as with the vast majority—they are law-abiding and need support from the state because they are in a vulnerable condition.

[Jeremy Hunt (South West Surrey) (Con) [V]]

I thank my right hon. Friend for a comprehensive response to Sir Simon Wessely’s superb review, which I was proud to commission at the request of the former Prime Minister, my right hon. Friend the Member for Maidenhead (Mrs May), whose commitment to mental health issues has been unparalleled. However, he knows that changes in the law only matter insofar as they affect the lives of real people, and his Department’s own data says that we still have more than 2,000 people with autism and learning disabilities locked up in mental health units, often supposedly temporarily, and sadly sometimes experiencing terrible breaches of human rights, such as the frequent use of restraint.

Will my right hon. Friend use this landmark moment to follow what Italy has done and close down all such units, so that these highly vulnerable people can be looked after more humanely in the community?

[Matt Hancock]

Absolutely. I want to see more people cared for in appropriate settings, which will often be in the community. My right hon. Friend set the target, as Health Secretary, to reduce the number of people with autism and/or learning disabilities in secure in-patient care. The 2,000 figure that he cites is a significant reduction, I am glad to say, from when he set that target and set that work in train—almost half. I want that number to continue to fall.

Of course, where there is a criminal justice element or restriction, that can be more difficult. However, we must make sure that the treatment and setting are appropriate for each and every person. Very often, a mental health setting is not appropriate for somebody with learning disabilities or somebody with autism, for whom it can in fact be the opposite of appropriate; it could be the worst place.

My right hon. Friend will know, as the Chair of the Select Committee, that the Care Quality Commission has in fact closed a number of settings during the pandemic, and we must make sure that we build more capacity. We have the budget in the spending review to do that and some of that building work is under way. There is a huge programme of work on the physical estate side and on training staff, as the hon. Member for Tooting (Dr Allin-Khan) mentioned, as part of the legislative change. No one element of that transformation works without all the others.

Oral Answers to Questions

Jeremy Hunt Excerpts

Tuesday 12th January 2021 Commons Chamber

[Matt Hancock]

Of course, all these things are being looked at. The pressures on the NHS are very significant. I also want to say to people who have a healthcare condition that is not covid-related that they should come forward to the NHS. The promise of the NHS, of always treating people according to their clinical need and not ability to pay, is crucial. It is just as crucial in these pressured times as it is at any other time. If you find a lump or a bump, if you have a problem with your heart, or if there is a condition for which you need to come forward for urgent treatment, then the NHS is open and you must help us to help you. So, yes, we absolutely will do everything we possibly can to address the pressures, including looking at the measures the hon. Lady set out, but also let the message go out that, if you need the NHS for other conditions, please do come forward.

[Jeremy Hunt (South West Surrey) (Con) [V]]

I congratulate my right hon. Friend on the speed of the vaccine roll-out and, in particular, his foresight in setting up the Vaccine Taskforce as far back as last April, which has made that possible. Personal thanks from my mum, who is getting her vaccine tomorrow at Epsom racecourse. Understandably, however, the public’s expectations about how quickly they will get their vaccine are now running well ahead of the system’s ability to deliver, causing floods of calls to GPs’ surgeries, which are already very busy. What can we do to set expectations among the public that getting to population-level immunity will be a marathon, not a sprint?

[Matt Hancock]

That is right. The Chair of the Health and Social Care Committee is wise to say that this will be a marathon, not a sprint. As of the early hours of this morning, we have vaccinated 39.9% of over-80-year-olds in England. We will reach all over-80-year-olds and ensure that they have the offer a vaccine in the coming weeks, and we will reach all of the top four priority groups by 15 February. We are on track and I am confident that we will deliver that. The other message that my right hon. Friend will perhaps help all of us to pass on to all his constituents, including his mum, is that the NHS will get in contact with them and offer them an appointment. That is the best and fairest way in which we can get the roll-out happening.

Covid-19: Vaccinations

Jeremy Hunt Excerpts

Monday 11th January 2021 Commons Chamber

[Madam Deputy Speaker (Dame Eleanor Laing)]

We now go to the Chairman of the Health and Social Care Committee, Jeremy Hunt.

[Jeremy Hunt (South West Surrey) (Con) [V]]

I congratulate the Minister on getting this programme off to a flying start: to vaccinate 2 million people, including a third of over-80s, six weeks after the first dose was approved is an extraordinary achievement unmatched by any similar country. May I ask him about the speed of the roll-out? Many people want teachers to be jabbed as quickly as possible, but is it the case that all those in groups 1 to 4 will need their second jabs before we can make real inroads into other key groups? And will he publish the breakdown of numbers vaccinated not just by region but by local authority area, because a lot of people would like to know just how many people have been vaccinated in their local area?

[Nadhim Zahawi]

I am grateful for my right hon. Friend’s compliment and this is only the start. I hope that, as we progress in the weeks and months to come, the focus and the rate of output will continue to rise.

My right hon. Friend raises an important point around the critical workforce for the economy, like teachers. The Joint Committee on Vaccination and Immunisation looked at all these issues and has come out very clearly in favour of us vaccinating the nine cohorts that are most vulnerable to dying from covid-19, hence why that is absolutely our focus.

We are absolutely committed to making sure that people get two doses, so if they have received their Pfizer first dose, they will get their Pfizer second dose within 12 weeks of the first dose. Similarly, if they have had their AstraZeneca first dose, they will get their AstraZeneca second dose within 12 weeks. So those people whom we will begin to reach in March, where we have to deliver their second dose, will absolutely get their second dose. But to my right hon. Friend’s point, the more vaccine volumes that will come, and we have tens of millions that will come through beyond February and into March, the faster we can begin to protect those nine categories in phase 1. The moment we have done that, then it is absolutely right that we should begin to look at categories like teachers and police officers—those who may be exposed in their workplace to the risks of this virus.

Of course, it is worth reminding the House that it is two weeks after the first dose, and three weeks after the first dose with AstraZeneca, that people begin to get that protection, not the moment they are jabbed, so there is that lag time as well. But my right hon. Friend’s point is well made: we need to make sure, as we protect greater and greater numbers of people in those nine categories, that we then move very quickly to the next dose.